INTRODUCTION
Diabetes mellitus (DM) refers to a group of common metabolic disorders that share the phenotype of hyperglycemia. 1 Several distinct types of DM are caused by a complex interaction of genetics and environmental factors. 1 It is characterized by high blood glucose levels resulting from defects in insulin production, insulin action, or both. 2, 3 8.8% of adults aged 20-79, are estimated to have diabetes. About 75% live in low and middle income countries. If these trends continue, by 2040 some 642 million people, or one adult in ten, will have diabetes.
It has been estimated by IDF that globally as many as 193 million people, or close to half (46.5%) of all people with diabetes, are unaware of their disease. Most of these cases are type 2 diabetes. Many of these cases present with diabetes related complications at the time of diagnosis. Diabetes and its complications are major causes of early death in most countries. Cardiovascular disease is one of the leading causes of death among people with diabetes and can account for 50% or more of deaths due to diabetes in some populations. Several steps have to be taken in order to control the epidemic of diabetes and to recognize the complications of diabetes at an early stage thereby reducing morbidity and mortality due to diabetes related complications.
HbA1c is used to measure the long term glycemic control in patients with diabetes. HbA1c has been a major tool in assessing the adequacy of therapy and need for intervention in patients with poorly controlled diabetes mellitus. However, HbA1c usually does not predict ongoing inflammation and diabetes associated complications accurately.
Clues to the involvement of inflammation in diabetes date back to more than a century ago, when high doses of sodium salicylate (5.0-7.5 g/d) were first demonstrated to diminish glycosuria in diabetic patients having "the milder form of the disease," presumably type 2 diabetes. Neutrophils, the key effector cells of the innate immune system, play a pivotal role in T2DM and cardiovascular disease pathogenesis. 4 Various neutrophil dysfunctions have been reported in T2DM patients including cell stiffening, impaired chemotaxis and phagocytosis which lead to increased susceptibility to bacterial infections. [5] [6] [7] [8] [9] Despite the adverse changes of leukocytes in diabetes, there are currently no specific measurements to assess patient's leukocyte phenotypes or inflammatory status.
Neutrophil lymphocyte ratio (NLR) is a potential marker to determine inflammation in various cardiac and noncardiac disorders because it has a superior predictive, diagnostic and discriminative ability than total WBC count. It is used to predict the prognosis of diseases such as acute myocardial infarction (MI), stroke, and heart failure. However, there haven't been many studies directly correlating HbA1c and NLR in patients with type 2 diabetes mellitus. The present study was conducted to assess the correlation between NLR and glycaemic control in patients with type 2 diabetes mellitus.
Aims and objectives
• To measure neutrophil lymphocyte ratio in patients with type 2 diabetes mellitus.
•
To study the correlation between neutrophil lymphocyte ratio and glycemic control in type 2 diabetes patients.
METHODS

Study population
This observational study was carried out at Department of General Medicine, Bangalore Medical College and Research Institute, Bengaluru between November 2017 and December 2018. The study was conducted after getting the institutional ethical committee clearance. All the patients gave informed written consent for the study. 100 patients with type 2 diabetes mellitus according to ADA criteria who were aged more than 18 years were included in the study. Patients were included in the study by simple random sampling. Patients with acute infections, leukocytosis or leukocytopenia, chronic cardiac, renal or hepatic disorders were excluded from the study. Patients who were a known case of autoimmune disorders, malignancy or hematological proliferative disorders were also excluded from the study. Patients who had received anti-inflammatory or immunosuppressive therapy were also excluded from the study.
Patients were divided into three groups. Group A with HbA1c ≤7, Group B with 7< HbA1c <9 and group C with HbA1c ≥9. A detailed history and general physical examination were conducted.
Blood parameters
After overnight fast, venous samples were collected and total leukocyte count (TLC), neutrophil and lymphocyte count were measured by automated hematology analyzer. Neutrophil lymphocyte ratios (NLR) were estimated by dividing the absolute neutrophil ratio to absolute lymphocyte ratio. HbA1c level was measured by high performance liquid chromatography using automated ion exchange method.
Statistical analysis
Data were presented as mean±standard deviation(SD). SPSS software was used for statistical analysis. T test was used for continuous variables and chi square test for categorical variables. ANOVA test was used to compare three groups. A p value of <0.05 was considered statistically significant. Linear regression analysis was performed to investigate any direct relationship between HbA1c and NLR, WBC count, age, sex, BMI and duration of diabetes.
RESULTS
The sample size in our study was 100 patients. The baseline demographic characteristics of study population is given in table 1. The mean age of patients included in group A, B and C was 55.222±4.3, 55.527±9.6 and 54.472±10.8 respectively ( Figure I ). There was no statistically significant difference between the three groups (p<0.218). Similarly there was no statistically significant difference between the three groups in terms of demographic characteristics including gender, BMI and duration of diabetes (Table 1, Figures 2) . 5 patients (2 from group B and 3 from group C) were on insulin therapy. The rest of the study population was on oral hypoglycemic agents. 38 patients in the study population had hypertension as a co-morbidity. Table 2 ). The mean HbA1c of patients in group A, B and C was 6.36, 7.82 and 11.69 respectively.
Figure 2: Gender distribution.
The total count was significantly higher in group C as compared to groups A and B (7771.11±2027.5, 8316.02±1625.9 and 9105.455±2310.1 respectively; p<0.05; Figure III) . The neutrophil lymphocyte ratio (NLR) was significantly higher in group C as compared to groups A and B (2.496±1.2, 2.701±1.5 and 4.17±2.3; Figure 4 ). The p value was statistically significant (p<0.05). Linear regression analysis showed that NLR correlated positively with HbA1c. 
DISCUSSION
In our study, there is a positive correlation between NLR and HbA1c. There are not many studies directly correlating NLR and glycemic control although several studies have observed a link between NLR and insulin resistance, metabolic syndrome and atherosclerosis. To our knowledge, there are only few studies directly correlating NLR and glycemic control and this study is the second in south Indian population.
Figure 4: Comparison of NLR among three groups.
Neutrophil lymphocyte ratio NLR is a potential marker to determine inflammation in various cardiac and noncardiac disorders because it has a superior predictive, diagnostic and discriminative ability than total WBC count. It is used to predict the prognosis of diseases such as acute myocardial infarction (MI), stroke, and heart failure. Predictive value of NLR is comparable to various other inflammatory markers such as C-reactive protein (CRP), tumor necrosis factor (TNF-α) and interleukin (IL-6) in the detection of subclinical inflammation and endothelial dysfunction in various clinical studies. 10 Unlike the total WBC count, NLR is a dynamic parameter and appears to possess a superior predictive value over total leukocyte count. 11 NLR has various advantages over other inflammatory markers because of its wide availability, low cost, reliability and easy lab detection. Even patients with increase NLR but normal TLC count could have increased risk of atherosclerosis related diseases. [12] [13] [14] HbA1c is commonly advised to measure the long term glycemic control and it also tells about the severity of hyperglycemia. 15 However HbA1c usually do not predict ongoing inflammation and diabetes associated complications accurately. NLR has a potential to be used to assess inflammatory state and the complications associated with diabetes.
Among the studies conducted outside India, Sefil et al, conducted a study in Turkey in 2013 and concluded that increased NLR may be associated with elevated HbA1c in type 2 diabetes patients. 16 Similarly Mazhar et al , conducted a study in Pakistan in 2016-17 and concluded that increased NLR is associated with elevated HbA1c and poor glycemic control in type 2 diabetes patients. 17 Shiny et al, revealed that increased NLR has strong association with glucose intolerance and insulin resistance in type 2 diabetic patients. 18 Oh et al , and Demirtas et al , also came to similar conclusions as our study. 19, 20 Of note is that several studies have consistently shown that NLR is also associated with diabetic nephropathy and diabetic retinopathy. [21] [22] [23] Drawbacks of our study include, small sample size, effects of different anti diabetic drugs used by patients could not be assessed and hypertension was a comorbidity in 38% of the study population.
CONCLUSION
NLR is an easily available, safe, cost effective and simple test. NLR is not only a marker of subclinical inflammation but also an indicator of poor glycemic control in patients with type 2 diabetes. NLR can be used as a screening test to identify type 2 diabetes patients more likely to develop diabetes related complications and initiate preventive measures and avoid/delay life threatening complications. NLR can also guide the physician in the resource limited settings like primary health centres (PHC) when to evaluate a patient with type 2 diabetes for microvascular and macrovascular complications. 
